Lung Neoplasms: all 7,334 studies
Page 37 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Detection and Metabolic Characterization in DOPA PET/CT of Brain MetastasesCompletedNCT04890028Not applicable
- A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawnNCT04889495
- Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesWithdrawnNCT04889066Phase 2
- Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer PatientsStatus unknownNCT04887545
- Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary MetastasesCompletedNCT04887298Phase 1/2
- A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04884009Phase 2
- Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung CancerStatus unknownNCT04882033Phase 1
- Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.CompletedNCT04881045Phase 1
- Energy for LymphocytesCompletedNCT04879316
- SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and ChemotherapyStatus unknownNCT04878107Phase 2
- A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLCCompletedNCT04878016Phase 3
- A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor TreatmentStatus unknownNCT04872634Phase 1/2
- A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung CancerTerminatedNCT04870112Phase 1
- Acceptance and Commitment Therapy in Patients With Advanced Lung CancerCompletedNCT04869267Not applicable
- Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer RadiotherapyStatus unknownNCT04867564
- Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung CancerStatus unknownNCT04865705Phase 2
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
- Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology TreatmentTerminatedNCT04862195Not applicable
- Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer OutpatientsCompletedNCT04859400Not applicable
- Prospective Primary Human Lungcancer Organoids to Predict Treatment ResponseCompletedNCT04859166
- Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung CancerCompletedNCT04857697Early Phase 1
- A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of ChemoimmunotherapyTerminatedNCT04856176Phase 2
- A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLCTerminatedNCT04849273Phase 1
- Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLCStatus unknownNCT04846452Phase 2
- Testing the Feasibility of a Simplified Workflow for Lung CancerCompletedNCT04844736Not applicable
- MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)Active, not recruitingNCT04841811Phase 3
- A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic TumorsWithdrawnNCT04841538Phase 1/2
- Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung CancerStatus unknownNCT04840758Phase 1/2
- A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLCStatus unknownNCT04840290Phase 3
- Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung CancerActive, not recruitingNCT04837716Phase 1
- Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:CompletedNCT04836975
- Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung CancerActive, not recruitingNCT04836728Phase 2
- Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung CancerSuspendedNCT04835025
- Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung CancerStatus unknownNCT04833205Phase 2
- Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung CancerCompletedNCT04830813Phase 3
- Early Access Program of Lazertinib in Republic of KoreaApproved for marketingNCT04829422
- Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung CancerStatus unknownNCT04828850Not applicable
- Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung CancerStatus unknownNCT04828395Phase 2
- Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung CancerStatus unknownNCT04827667
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- Keynatinib in Treated Patients with NSCLC and Brain MetastasesCompletedNCT04824079Phase 2
- A Nurse-Led Intervention for Fear of Progression in Advanced CancerActive, not recruitingNCT04819997Not applicable
- Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"CompletedNCT04819477Not applicable
- The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)CompletedNCT04818983
- A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung CancerActive, not recruitingNCT04818333Phase 1/2
- Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)Status unknownNCT04817046
- AI-EBUS-Elastography for LN StagingCompletedNCT04816981Not applicable
- To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 FusionStatus unknownNCT04814056Phase 4
- Lung Cancer Patients' Attitudes to a Second Course of RadiotherapyStatus unknownNCT04813068
- Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung CancerCompletedNCT04808050
- Exercise Capacity, Pulmonary Function and Physical Activity Level in Patients Lung Cancer Undergoing PneumonectomyCompletedNCT04807153
- Improving Utilization of Lung Cancer Screening in Underserved PA PopulationsActive, not recruitingNCT04806399Not applicable
- Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityActive, not recruitingNCT04804644Phase 3
- Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata StudyCompletedNCT04804137
- Assessment of the 90-day Mortality Risk Score After VATS LobectomyCompletedNCT04799509
- Effects of MSC Intervention on the Dyadic Mental Health of Lung Cancer Patients and Their CaregiversCompletedNCT04795700Not applicable
- Study of IDE397 in Participants With Solid Tumors Harboring MTAP DeletionActive, not recruitingNCT04794699Phase 1
- A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT04794010
- Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)CompletedNCT04793815Not applicable
- Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With PembrolizumabTerminatedNCT04791215
- a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung CancerStatus unknownNCT04790539Phase 2
- Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesTerminatedNCT04785287Phase 1/2
- The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line TherapyStatus unknownNCT04782622
- Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung CancerStatus unknownNCT04782089Not applicable
- Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal LymphadenectomyStatus unknownNCT04778826Not applicable
- Correlation of Pre- and Post-operative Cancer Imaging TechniquesCompletedNCT04776291Not applicable
- Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer PatientsCompletedNCT04776083Phase 3
- Application of Three-Dimensionally Printed Navigational Template in Lung BiopsyStatus unknownNCT04775901Not applicable
- BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective EvaluationCompletedNCT04775095
- A Clinical Evaluation of the Aliya™ System in Late Stage CancerTerminatedNCT04773275Not applicable
- Sleep Disorders in Patients With Suspected Lung Cancer Before and After Thoracic SurgeryStatus unknownNCT04759651
- FL-101 in Surgically Resectable Non-Small Cell Lung CancerWithdrawnNCT04758949Phase 2
- Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung CancerStatus unknownNCT04758481Not applicable
- A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung CancerStatus unknownNCT04757779Phase 2
- LUS to Assess Lung Injury After Lung LobectomyStatus unknownNCT04755478
- Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLCWithdrawnNCT04754815Phase 2
- Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot StudyStatus unknownNCT04753918Early Phase 1
- 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesCompletedNCT04752267Early Phase 1
- Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerActive, not recruitingNCT04751747Not applicable
- A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device.CompletedNCT04751162
- HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung CancerStatus unknownNCT04750083Phase 2/3
- Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung CancerStatus unknownNCT04749407
- Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and AnorexiaCompletedNCT04748523Not applicable
- Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With DurvalumabTerminatedNCT04748419Phase 1/2
- Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung CancerCompletedNCT04742192
- Managed Access Programs for INC280, CapmatinibNo longer availableNCT04741789
- Cios Mobile 3D Spin for Robotic BronchoscopyCompletedNCT04740047
- Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04740021Phase 2
- Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung CancerCompletedNCT04736173Phase 2
- Using e-Nose Technology to Identify Early Lung CancerActive, not recruitingNCT04734145
- A Phase 1/2 Study of SC-43 in Combination With CisplatinStatus unknownNCT04733521Phase 1/2
- Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung CancerCompletedNCT04732520Not applicable
- Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung CancerStatus unknownNCT04731909Not applicable
- Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung CancerCompletedNCT04730999Phase 2
- Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialActive, not recruitingNCT04728230Phase 1/2
- Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)CompletedNCT04727853Phase 2
- ProCaLung: Project on Cancer of the LungStatus unknownNCT04726358
- Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy.Status unknownNCT04722406
- Lung Resection and Pulmonary RehabilitationCompletedNCT04722393Not applicable
- Korea Post Marketing Surveillance (PMS) Study of VizimproCompletedNCT04721106